SUPRAMOLECULAR DRUG CARRIERS IN CANCER THERAPEUTICS

Manisha Saini*, Anil Sharma, Vikas Nagar

G.D Goenka University, Sohna, Haryana, India

ABSTRACT

Cancer has a significant effect on society worldwide. Statistics on cancer explain what happens in a large set of people and give a real picture of the burden on society. A number of cancer treatments are accessible nowadays and enormous numbers are in the pipeline, but society still faces several lacks in full therapy cure. The objective is to determine, parallel to the kinds and uses of supramolecular drug carriers, and the incidence and incidences of cancer with various medical systems concentrated primarily on targeted structures. Rational drug delivery designs have shown important interest in enhancing therapeutics in latest years with regard to leveraging supramolecular chemistry that is ‘‘chemistry beyond molecules.'' Particular tunable and dynamic non-covalent interaction of engineering can be used for drug delivery. Advantages of this include molecular composition control, improved drug integration and targeting pathways, and new delivery devices which respond to a various physiological indicators. One of the largely recognizable motivations for supramolecular drug delivery is macrocyclic hosts-guest complexes. The scope of this review is to give a clear picture that how supramolecular drugs carrier plays an effective role in cancer treatment.

Keywords:

Cancer, sarcoma, targeted therapy, supramolecular carrier